Ropes & Gray's work advising Pfizer on its $10 billion acquisition of Metsera has been recognized as Matter of the Year at the 2026 GCR Awards by Global Competition Review.
Ropes & Gray served as lead antitrust counsel to Pfizer in its acquisition of Metsera, an obesity drug developer. The firm's work with antitrust authorities was instrumental in securing the deal over a rival bidder and obtaining early termination of the HSR waiting period, positioning Pfizer to compete in the fast-growing obesity and diabetes drug market.
The annual GCR Awards honor the world's leading antitrust lawyers, economists, enforcers, and major competition cases from the past year.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.